ICCS is a non-profit Academic Research Body established in 1989, and since its foundation it carries out research and development activities in the fields of all diverse aspects of telecommunications, computer systems and techniques and their application in almost all areas of advanced technological research and innovation. It is the most active Academic Research Institute in the country, involving 13 Research Units, 28 Laboratories, more than 120 Faculty members and Research Scientists and more than 500 Associate Scientists (including Ph.D. students).

ICCS is very active in European co-funded research activities and has been partner, technical director or coordinator of hundreds of EU projects in various programs over the years (e.g. EC, ISIS, RACE II, ESPRIT, IES, ACTS, INFOSEC, BRITE-EURAM, STRIDE, MIP-Informatics, Telematic Applications, IST, GROWTH, QoL, JOULE, ENERGIE, FP6, FP7, HORIZON, Marie Curie, etc.).

In RETENTION, ICCS participates with the Biomedical Engineering Lab, operating in the Institute’s framework. The Biomedical Engineering Laboratory (BEL), legally established within the School of Electrical and Computer Engineering of NTUA, operates since 1990. BEL had the presidency of E-Health Forum 2014, which was organized under the auspices of the Greek EU Presidency in cooperation with the European Commission, and was one of the founders of HL7 Hellas. Its activities cover a wide range of Basic and Applied Research in specialised Biomedical Engineering fields, focusing on the development of applicable end-products.
The main research areas of BEL’s expertise include: Medical Data Management Systems, Medical Informatics, Telemedicine, Bio-signal and Medical Image processing, Biosensors, Augmented Reality in Medicine and Healthcare, Neural Networks in Medical Applications, Clinical Decision Support Systems, Data Fusion Algorithms, but also SOA Architecture, Web services and Interoperability Standards as well as Home Care Systems and Services and e-Health Applications in general.

Based in five campuses (Bologna, Cesena, Forlì, Ravenna, Rimini), with a branch in Buenos Aires, it offers a teaching catalogue diversified and tailored to the needs of present-day society: over 200 degree programmes among its 32 Departments and 11 Schools are offered to over 81,000 students. 5,000 graduates are enrolled in PhDs and 3rd cycle programmes. As a comprehensive research university, Alma Mater invests in the multidisciplinary cross-cultural approach and in the inseparable connection between research and teaching.
One of the most active universities leading and participating in European research and academic cooperation projects, Bologna has formed knowledge alliances with industry and public/private organizations. It is a hub of international networks. Beyond its close European links, it enjoys multiple connections with America, Africa, Asia and Australia. Research and Innovation are a priority of the University mission.

With regard to Innovation, UNIBO filed 86 new patent applications in 2017, of which 25 are new registrations, thereby giving rise to an active patent portfolio of over 370 patents related to more than 140 inventions. It also has an active portfolio of more than 20 patented plant varieties, 80% of which are increased in value through active licenses with geographic coverage in countries in different parts of the world. UNIBO set up or accredited 27 spin-off companies up to 2017 and can also count Almacube, as a business incubator that managed 15 incubated companies in 2017. With regard to the capability of attracting funding for research and innovation, UNIBO is very active both at National and European level in all the research areas.

Activities related to competitive funding programs are supported by the Research and Third Mission Division, with more than 10 years’ experience and about 50 people assisting the research groups in the whole project lifecycle. A Research Development Office deals with the UNIBO strategic positioning at local, national and international level, through integrated networking and lobby activities in each specific research area. While the Programs & Projects Office supports the UNIBO researchers from the proposal submission to the implementation phase of the projects with technical, legal, financial and administrative expertise.
These Offices strictly cooperate between each other and in strictly connection with the Knowledge Transfer Office, for the Innovation Management expertise and the IP protection and exploitation, and the take up and commercialization of project results. Thanks to its scientific excellence and a central Project Management support working closely, UNIBO has gained a considerable experience in International and European research projects, successfully participated in FP7: with 274 projects funded in 2007-2013 (58 of them as coordinator) and 87,8 M€ of funding, UNIBO is the second Italian university for the attractiveness of European funding for research, 37st in the European ranking of institutions of higher education.

In Global Rankings UNIBO occupies the top 10 national rank in major league tables such as QS World University Rankings, THE World University Rankings, ARWU World University Rankings. In 2017 it ranked 29 in the GreenMetric World University Rankings measuring the university’s vision and policy for sustainability. In Horizon 2020, UNIBO is so far involved in 262 funded projects (69 as coordinator).

Hospital Universitario Ramón y Cajal (SERMAS-HURC)
Hospital Universitario Ramón y Cajal is a 1,000-bed university hospital in Madrid founded in 1977, affiliated to Universidad de Alcalá and part of the Servicio Madrileño de Salud (SERMAS). It provides comprehensive health care in all medical and surgical specialties, and it includes an established research institute: Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), which encompasses basic, translational and clinical research departments. The institute has all the required infrastructures to perform phase I to IV clinical trials, including full laboratory and imaging equipment and an ethical committee.
It ranks first in Madrid and third in Spain in production of biomedical research, working in partnership with more than 50 international leading centres. SERMAS-HURYC consists of 39 research groups that focus their activities on five major areas: neurosciences; microbiology, immunology and infection; chronic diseases and cancer; epidemiology and health technology; cardio-metabolism and systems pathology. It also hosts many other independent researchers from the clinical area.
All this critical mass generates +1000 publications and 200 new clinical trials per year. The knowledge created by all this activity has resulted in more than 80 innovation projects, and 25 patent families. SERMAS-HURYC has a business development office, giving support to all projects from their very beginning, “from the idea to the market”; this office includes one innovation and technology transfer unit, certified by UNE 166002:2014, as well as one international projects unit.

FORTH/IMBB: The Institute of Molecular Biology and Biotechnology (IMBB) is based in Heraklion (Crete), and is conducting basic and applied research in established and emerging areas of Biomedical science. IMBB was founded in 1983 and is part of the Foundation of Research and Technology-Hellas (FORTH), one of the largest research centers in Greece.

FORTH/IMBB-BR www.imbb.forth.grl & www.bri.forth.gr was founded in 1998, is the section of FORTH/IMBB focusing on biomedical research and is located in Ioannina, Greece. The work in this project will be implemented by the Unit of Medical Technology & Intelligent Information Systems (MedLab). MedLab is a highly innovative research unit working in the fields of Biomedical Engineering and development of Intelligent Information Systems.

The technologies offered by Sphynx include sophisticated event processing and analytics, security monitoring and testing, intrusion detection, fraud management, and incident response. Sphynx deploys off-the-shelf hardware components along with its custom software to provide tools including its security audit and certification platform and its model-driven big data analytics platform. Via its consulting services, Sphynx has expertise in providing customized solutions depending on client needs as well as more general training on analytics, security assessment and certification and cyber intelligence.

Via its consulting services, Sphynx has expertise in providing customized solutions depending on client needs as well as more general training on analytics, security assessment and certification and cyber intelligence.
Sphynx has significant expertise in cyber security solutions and cyber security and privacy assurance solutions. Its security and privacy assurance platform offers multiple and complementary types of analysis of cyber threats, vulnerabilities and operational security and privacy conditions based on static analysis, penetration testing and continuous monitoring, enabling both signature and anomaly based checks, of all levels of typical implementation stacks of cyber systems.
By virtue of being model driven, the security and privacy assurance platform of Sphynx offers high levels of automation and customisation to different security standards and organisations. Currently, Sphynx is also developing cyber range capabilities on the top of its security and privacy assurance platform, which can be driven by the actual security assessments carried out for different organisations, and thus realise custom cyber security training programmes.

By applying a decade of experience in innovation management, i2Grow helps define product strategies that maximize the benefits for the end users in both B2C and B2B value proposition types of offer. Based in Milano, since 2009 we support customers in ideate, innovate, implement and communicate Digital Research projects.

SIEMENS CT Romania is a Romanian branch of these activities. CT has an extensive expertise and experience in all areas of software development, working for a large variety of sectors like energy, mobility and industrial manufacturing or services to mention but a few.

Current research capacity and expertise of the department in Brasov (acting inside Siemens SRL, Romanian house company of Siemens) encompasses fields like Data Analytics and Monitoring, Constraint Based Configurations and Schedulers, Complex Event Processing, Remote Diagnostics Systems, Data Acquisition Architectures, Future Internet Technologies, Industrial-grade DevOps, Environment orchestration, Semantic Data Modelling, Data Aggregation, Federated Platforms.

The department acts at the global scale in Siemens Corporate Technology division, core technological house of the corporation. Due to this unique position, the group contributes in the large mesh of knowledge of CT experts, with large access to the EU funded projects where Siemens CT already contributes. From the local group perspective, the expertise offered is centred around some main research cores: Knowledge based systems (with a strong focus on Constraints Based Systems and the mix with Semantic technologies), Event Processing and Event Driven Architectures, Internet of Things in complete stack from device enablement and security, middleware up to predictive analytics, Multi-Agent Systems, Big Data analytics, Cloud Computing and Networking technologies, embedded systems, Intelligent Energy Grid Management or Cities Infrastructures.